Table 3. The association between baseline and the change in standardized symptom scores.
n | Baseline (mean ± SD) | Follow-up (mean ± SD) | P-value | |
Normal manometry, BEDQ, six-month | 19 | 10.8 ± 10.5 | 6.4 ± 10.4 | 0.009 |
EGJOO, BEDQ, six-month | 23 | 12.0 ± 10.8 | 10.8 ± 10.3 | 0.681 |
Normal manometry, BEDQ, 16-month | 6 | 9.0 ± 10.5 | 2.7 ± 3.0 | 0.068 |
EGJOO, BEDQ, 16-month | 9 | 9.6 ± 10.1 | 6.1 ± 5.0 | 0.181 |
Normal manometry, GerdQ, six-month | 19 | 9.5 ± 3.3 | 8.1 ± 3.6 | 0.096 |
EGJOO, GerdQ, six-month | 23 | 7.7 ± 2.8 | 6.6 ± 2.7 | 0.165 |
Normal manometry, GerdQ, 16-month | 6 | 11.2 ± 3.0 | 7.8 ± 2.8 | 0.042 |
EGJOO, GerdQ score, 16-month | 9 | 8.3 ± 2.1 | 7.3 ± 1.9 | 0.137 |